–
Relmada Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−126
FY22:
−161
FY23:
−104
FY24:
−83.9
FY25:
−59.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−124
FY22:
−156
FY23:
−103
FY24:
−84.3
FY25:
−59.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−126
FY22:
−157
FY23:
−98.8
FY24:
−80.0
FY25:
−57.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−126
FY22:
−157
FY23:
−98.8
FY24:
−80.0
FY25:
−57.4
All amounts in millions USD